Elements to assure safe use (ETASU) in a REMS

  • PTCB PTCE
  • Federal Requirements
  • Select all that apply
  • Difficulty 3 of 5

Question

Which requirements can FDA impose as elements to assure safe use in a REMS? Select all that apply.

  1. Pharmacies must be specially certified before they can dispense the drug✓ Correct

    Correct. Requiring pharmacies to be certified is one ETASU option.

  2. The drug may be dispensed only in specific settings, such as hospitals or infusion centers✓ Correct

    Correct. Restricting the settings where a drug is dispensed is an ETASU option.

  3. The drug is dispensed only with documented safe-use conditions, such as a required lab result✓ Correct

    Correct. Dispensing can be tied to evidence of safe-use conditions like lab tests.

  4. Each patient who receives the drug is enrolled in a registry✓ Correct

    Correct. Patient registry enrollment is an ETASU option.

  5. The drug must be ordered from the wholesaler on a DEA Form 222✗ Incorrect

    Incorrect. Form 222 is a DEA ordering rule for schedule I and II drugs, not a REMS element.

  6. The buyer's name and address must be written in a logbook at the time of sale✗ Incorrect

    Incorrect. Purchase logbooks belong to the federal pseudoephedrine sales rules, not to REMS.

Answer

A. Pharmacies must be specially certified before they can dispense the drug · B. The drug may be dispensed only in specific settings, such as hospitals or infusion centers · C. The drug is dispensed only with documented safe-use conditions, such as a required lab result · D. Each patient who receives the drug is enrolled in a registry

Rationale

A REMS may include one or more elements to assure safe use. These can include certification of prescribers or pharmacies, limits on dispensing settings, evidence of safe-use conditions, patient monitoring or registries. DEA Form 222 and pseudoephedrine sales logbooks are addressed under separate federal requirements.

RememberETASU can mean certified prescribers or pharmacies, restricted settings, lab proof, monitoring or registries.

Sources

  • FDA Drug Topics: U.S. Food and Drug Administration · License: US government work (public domain) · Retrieved · Page 13
  • Tolvaptan (tolvaptan) oral prescribing information, Ascend Laboratories, LLC U.S. Food and Drug Administration (openFDA) · License: CC0 1.0 · Retrieved · Warnings and precautions · effective_time 20260826
  • Risk Evaluation and Mitigation Strategies | REMS U.S. Food and Drug Administration · License: US government work (public domain) · Retrieved · REMS in Action: An Example · page updated Tue, 05/20
  • United States Department of Justice U.S. Drug Enforcement Administration, Diversion Control Division · License: US government work (public domain) · Retrieved · Page 21; Page 87
  • U.S.C. Title 21 - FOOD AND DRUGS U.S. Government Publishing Office · License: US government work (public domain) · Retrieved · (3) Elements to assure safe use
  • What's in a REMS? U.S. Food and Drug Administration · License: US government work (public domain) · Retrieved · Required Activities or Clinical Interventions · page updated Fri, 01/26

Last verified: 2 independent automated checks Question ptcb-fr-00030, version 1

Checks are automated. No licensed clinician has reviewed this question. Check the sources and your program’s materials.

Report an error in this question. For education only; not medical advice. See all sources and licenses.

More PTCB PTCE sample questions